All SARS-CoV-2 / COVID-19 from the Institut Pasteur

It all started with an epidemic of pneumonia of viral appearance and of unknown etiology that emerged in China, in December 2019. On January 2020, the discovery of a new coronavirus was announced (SARS-CoV-2). This coronavirus is the agent responsible for the new infectious respiratory disease called Covid-19. All you want to know about SARS-CoV-2, the Covid-19 epidemic and the research projects conducted at the Institut Pasteur is on this webpage.


Discover our mobilization and the impact of our research in the response to the Covid-19 crisis.
You can also access all our scientific publications as well as mathematical modeling about the dynamics of the epidemic and the impact of control measures.


Here are the news, press releases and videos from the Institut Pasteur (located in Paris), which was mobilized as soon as the first cases were announced, following the declaration of the epidemic by the Chinese authorities.

Le SARS-CoV-2 détourne les nanotubes reliant les neurones afin de les infecter
COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both during the acute phase of the disease and over the long term with "long COVID" syndrome. But the way in which the infection reaches the brain was previously unknown. Scientists from Institut Pasteur and CNRS laboratories have used state-of-the-art electron microscopy approaches to demonstrate that SARS-CoV-2 hijacks nanotubes, tiny bridges that link infected cells with neurons.
Eclairage sur la réplication du SARS-CoV-2 dans des cellules de chauve-souris
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the first time. They demonstrated the existence of species-specific and cell-specific immune responses.
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised people are at greater risk of developing severe forms of COVID-19. Monoclonal antibodies currently offer the best approach, both as a preventive and curative treatment for these patients. Scientists from the Institut Pasteur and Inserm identified two potent neutralizing antibodies from convalescent COVID-19 individuals that proved effective against SARS-CoV-2 variants of concern.



Fiche Maladie Covid-19 - Institut Pasteur

All the information about Covid-19 disease, caused by the SARS-CoV-2 coronavirus (cause, symptoms, transmission, prevention, treatment, etc.). The Covid-19 fact sheet is updated regularly.




Coronavirus : attention aux fausses informations circulant sur les réseaux sociaux - Institut Pasteur

Coronavirus SARS-CoV-2 and Covid-19: beware of false information


Back to top